1st TIF Pan American Conference and 2nd RAIN Summit: A Milestone of Hope
Thalassaemia International Federation (TIF) shared a grateful post on LinkedIn:
”What an unforgettable journey in Washington D.C.!
As we look back on the 1st TIF Pan American Conference and the 2nd RAIN Summit, we are deeply grateful to our incredible Sponsors who helped turn this vision into reality.
Your generous support empowered vital conversations and new connections among the Thalassaemia, SCD, and Rare Anaemias communities across the Americas.
Thank you for standing with us — for care, for science, for hope!”
The 1st TIF Pan American Conference and 2nd RAIN Summit in Washington D.C. marked an unforgettable milestone for the Thalassaemia, SCD, and Rare Anaemias communities.
TIF thanked all the sponsors: Agios Pharmaceuticals, Bristol Myers Squibb, Vertex Pharmaceuticals, bluebird bio, Chiesi Global Rare Diseases, Novo Nordisk and Sanofi.
Thanks to the support of dedicated sponsors, vital conversations and new collaborations flourished—advancing care, science, and hope across the Americas.
Do not miss the latest updates on the waves in the hematology field, read Hemostasis Today.
-
Aug 4, 2026, 21:28New Frontiers in Platelet Biology – BJHaem
-
Aug 4, 2026, 20:48New Real-World Data on Efanesoctocog Alfa From France – CRH French Reference Center for Hemophilia Lyon
-
Aug 4, 2026, 20:37Hisam Siddiqi: Haemoglobinopathy Basics – A Quick Guide to Thalassaemia
-
Aug 4, 2026, 20:36Ifeanyichukwu Ifechidere: AI May Soon Interpret Coagulation Results Better Than Some Healthcare Professionals
-
Aug 4, 2026, 20:35Ediga Naga Pradeep Kumar: Excited to Share My Latest Data Analytics Project – Stroke Risk Analysis Dashboard
-
Aug 4, 2026, 20:34Amar Shah: Improving Thrombolysis for Acute Stroke Through Quality Improvement
-
Aug 4, 2026, 20:33Federica Sepe: Are Biomarkers Finally Ready for Precision Stroke Medicine?
-
Aug 4, 2026, 20:10Kabir Olaniran: Sickle Cell Trait and Chronic Kidney Disease Risk
-
Aug 4, 2026, 19:57Toby Richards: Iron Deficiency Beyond Anaemia in Female Triathletes